The net worth of the reprocessed medical devices market in the Asia Pacific region is expected to be US$ 428.4 million in 2023. By 2033, the market is estimated to reach US$ 1,639.4 million, expanding at a CAGR of 14.4% in the meantime.
Practitioners in the healthcare sector are exploring the idea of deploying medical devices that are composed of previously used or reprocessed medical devices. This approach is gaining extreme importance with the increasing amounts of medical debris, which is escalating at an alarming speed.
The Market is being Spearheaded by:
Market Growth is Challenged by:
Abounding Opportunities for Manufacturers:
| Attributes | Details |
|---|---|
| Asia Pacific Reprocessed Medical Devices Market Size (2022) | US$ 381.8 million |
| Asia Pacific Reprocessed Medical Devices Market Size (2023) | US$ 428.4 million |
| Asia Pacific Reprocessed Medical Devices Market Projected Size (2033) | US$ 1,639.4 million |
| Value CAGR (2023 to 2033) | 14.4% |
| Value CAGR (2018 to 2022) | 10.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In the historical timeframe, the market observed a market valuation of US$ 381.8 million in 2022. Within the historical period, the market expanded at a CAGR of 10.1%.
Surge in the medical waste resulted in the adoption of reprocessed medical devices. Since its inception, reprocessed medical devices have been rising in developed as well as developing economies. Their heightened utilization is driven by factors like government initiatives to diminish waste generation from medical devices and escalating development of reprocessed devices and services.
Over the forecast period, the market is projected to be driven by increasing awareness pertaining to sustainable healthcare practices. Exploration of new markets and strategies to boost automated pharmaceutical workflow and encourage medical device reprocessing systems are projected to aid market growth.
Heightened focus on the reduction of emissions related to the use of medical devices is projected to augment the Asia Pacific market for reprocessed medical devices. Take for example, in January 2021, researchers from the environmental safety division of Fraunhofer-Gesellschaft announced that by deploying a reprocessed medical catheter as a substitute, global warming impact was reduced by 50.4%.
From 2023 to 2033, the market is projected to register a CAGR of 14.4%. In 2023, the market is anticipated to reach US$ 428.4 million, and by 2033, the market is projected to attain US$ 1,639.4 million.
| Country | Australia |
|---|---|
| Value Share % (2022) | 11.7% |
| Forecast CAGR % (2023 to 2033) | 14.2% |
| Country | New Zealand |
|---|---|
| Value Share % (2022) | 2.8% |
| Forecast CAGR % (2023 to 2033) | 12.9% |
| Country | China |
|---|---|
| Value Share % (2022) | 18.9% |
| Forecast CAGR % (2023 to 2033) | 18.8% |
| Country | India |
|---|---|
| Value Share % (2022) | 12.5% |
| Forecast CAGR % (2023 to 2033) | 18% |
| Country | South East Asia |
|---|---|
| Value Share % (2022) | 15.3% |
| Forecast CAGR % (2023 to 2033) | 14.8% |
| Country | Japan |
|---|---|
| Value Share % (2022) | 29.4% |
| Forecast CAGR % (2023 to 2033) | 11.9% |
Japan has acquired a massive share of 29.4% in the Asia Pacific reprocessed medical devices industry. Due to its high maturity levels in the market, the Japan market is projected to assume a comparatively low CAGR over the forecast period, i.e., 11.9%. The market growth in the country can be attributed to the focused concentration on technical advances. Additionally, the established healthcare infrastructure in Japan is also giving impetus to market growth. Environmental considerations and cost-saving measures by the Japanese government are also fueling the adoption of reprocessed medical devices.
Following Japan, China holds a significant portion of the market. In 2022, China reprocessed medical devices industry gained an 18.9% market share. Over the forecast period, the China market is projected to leap at a CAGR of 18.8%. The market is driven by:
South East Asia obtained a 15.3% market share in 2022. In the assessment period, South East Asia is projected to expand at a CAGR of 14.8%. The market is being driven by the complex healthcare infrastructure. Moreover, the governmental encouragement for sustainable healthcare practices to develop a supportive environment for the adoption of reprocessed medical instruments is also projected to boost the market growth.
The India reprocessed medical devices industry displayed a market share of 12.5% value share in 2022. Over the foreseeing years, the market is projected to expand at 18% CAGR. The propelling healthcare sector in the country offers several opportunities for the acceptance of reprocessed medical devices. The large population in India, surging cognizance about cost-effective healthcare solutions, and increasing healthcare expenditure are all projected to expand the Indian market.
Australia acquired an 11.7% value share in 2022. In the review period, the market is anticipated to expand at 14.2% CAGR. The market is propelled by:
Principal Consultant
| Segment | Cardiology Devices |
|---|---|
| Market Share (2022) | 59.52% |
Based on devices, cardiology devices gained a value share of 59.52% in the Asia Pacific reprocessed medical devices industry in 2022. Increasing cases of cardiovascular conditions are increasing the demand for cardiology devices like catheters, pacemakers, defibrillators, etc. Reprocessing these devices minimizes the costs and ascertains the presence of these life-saving equipment for patients in need.
| Segment | Hospitals |
|---|---|
| Market Share (2022) | 53.64% |
Hospitals gained a 53.64% market share in 2022. Hospitals are expected to observe a high adoption rate of reprocessed medical devices owing to surging hospital expenses. In addition to this, supportive government policies for these devices are also projected to have a positive impact on the segment growth.
Companies providing reprocessed medical devices are coming into joint ventures, collaborations, and other strategies, to enhance their market share. This also offers the advantage of improving their offering for reprocessed medical devices.
Market leaders are witnessing organic as well as inorganic activities to expand their growth in the market. For example, Medline Industries reported in July 2021 that its Medline ReNewal division of medical device reprocessing attained a new milestone by successfully gaining 5.3 million medical devices for reprocessing. This diverted above one million pounds of waste from landfills and avoided around 1,500 metric tons of carbon dioxide from being released into the air. Such initiatives assisted the company in efficiently reducing medical waste.
Several firms acquired or partnered with other firms to efficiently manage expenses and enhance the quality of the deliverables. For example, Innovative Health collaborated with Acutus Medical in October 2019 to offer advanced electrophysiology (EP) technology to enhance patient outcomes in a cost-efficient manner. With this partnership, both companies delivered healthcare providers an entire array of EP products, consisting of a broad portfolio of reprocessed EP devices.
Previously, in September 2018, Vanguard acquired Pioneer Medical Devices AG to improve its medical device reprocessing services. This assisted the corporation in broadening its product portfolio.
Key Players
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value and MT for Volume |
| Region Covered | Asia Pacific |
| Key Countries Covered | China, Japan, Australia, India, South East Asia, New Zealand, The Rest of the Asia Pacific |
| Key Segments Covered | Product Type, Classification, Reprocessing Method, End User, and Countries |
| Key Companies Profiled | Stryker Sustainability Solutions, Inc.; Medline ReNewal; Hygia Health Services, Inc.; Cleanpart GmbH; ReNu Medical, Inc.; SureTek Medical; NEScientific; Others |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is projected to reach US$ 1,639.4 million by 2033.
Medline ReNewal and Hygia Health Services, Inc. are the top players in the market.
Japan is projected to hold a sizeable market share over the forecast period.
The market is projected to register a CAGR of 14.4% through 2033.
The market value is expected to be US$ 428.4 million in 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Gastroenterology Devices 5.3.2. Cardiology Devices 5.3.3. Laparoscopy Devices 5.3.4. Orthopaedic/Arthroscopic Devices 5.3.5. ENT Devices 5.3.6. Others 5.3.6.1. Pulse Oximetry Sensors 5.3.6.2. Ultrasound Catheters 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Classification 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Classification, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Classification, 2023 to 2033 6.3.1. Critical 6.3.2. Semi-Critical 6.3.3. Non-Critical 6.4. Y-o-Y Growth Trend Analysis By Classification, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Classification, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Reprocessing Method 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Reprocessing Method, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Reprocessing Method, 2023 to 2033 7.3.1. In-House 7.3.2. Third Party Assisted 7.3.3. Non-Compliant Reprocessors 7.4. Y-o-Y Growth Trend Analysis By Reprocessing Method, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Reprocessing Method, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Diagnostic Centres 8.3.3. Ambulatory Surgical Centres 8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Product Type 10.2.3. By Classification 10.2.4. By Reprocessing Method 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Classification 10.3.4. By Reprocessing Method 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product Type 11.2.3. By Classification 11.2.4. By Reprocessing Method 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Classification 11.3.4. By Reprocessing Method 11.3.5. By End User 11.4. Key Takeaways 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Product Type 12.2.3. By Classification 12.2.4. By Reprocessing Method 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Classification 12.3.4. By Reprocessing Method 12.3.5. By End User 12.4. Key Takeaways 13. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.1.4. Singapore 13.2.1.5. Thailand 13.2.1.6. Indonesia 13.2.1.7. Australia 13.2.1.8. New Zealand 13.2.1.9. Rest of Asia Pacific 13.2.2. By Product Type 13.2.3. By Classification 13.2.4. By Reprocessing Method 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Classification 13.3.4. By Reprocessing Method 13.3.5. By End User 13.4. Key Takeaways 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product Type 14.2.3. By Classification 14.2.4. By Reprocessing Method 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Classification 14.3.4. By Reprocessing Method 14.3.5. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product Type 15.1.2.2. By Classification 15.1.2.3. By Reprocessing Method 15.1.2.4. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product Type 15.2.2.2. By Classification 15.2.2.3. By Reprocessing Method 15.2.2.4. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product Type 15.3.2.2. By Classification 15.3.2.3. By Reprocessing Method 15.3.2.4. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product Type 15.4.2.2. By Classification 15.4.2.3. By Reprocessing Method 15.4.2.4. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product Type 15.5.2.2. By Classification 15.5.2.3. By Reprocessing Method 15.5.2.4. By End User 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product Type 15.6.2.2. By Classification 15.6.2.3. By Reprocessing Method 15.6.2.4. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product Type 15.7.2.2. By Classification 15.7.2.3. By Reprocessing Method 15.7.2.4. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product Type 15.8.2.2. By Classification 15.8.2.3. By Reprocessing Method 15.8.2.4. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product Type 15.9.2.2. By Classification 15.9.2.3. By Reprocessing Method 15.9.2.4. By End User 15.10. China 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product Type 15.10.2.2. By Classification 15.10.2.3. By Reprocessing Method 15.10.2.4. By End User 15.11. Japan 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product Type 15.11.2.2. By Classification 15.11.2.3. By Reprocessing Method 15.11.2.4. By End User 15.12. South Korea 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product Type 15.12.2.2. By Classification 15.12.2.3. By Reprocessing Method 15.12.2.4. By End User 15.13. Singapore 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product Type 15.13.2.2. By Classification 15.13.2.3. By Reprocessing Method 15.13.2.4. By End User 15.14. Thailand 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product Type 15.14.2.2. By Classification 15.14.2.3. By Reprocessing Method 15.14.2.4. By End User 15.15. Indonesia 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product Type 15.15.2.2. By Classification 15.15.2.3. By Reprocessing Method 15.15.2.4. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product Type 15.16.2.2. By Classification 15.16.2.3. By Reprocessing Method 15.16.2.4. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product Type 15.17.2.2. By Classification 15.17.2.3. By Reprocessing Method 15.17.2.4. By End User 15.18. GCC Countries 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Product Type 15.18.2.2. By Classification 15.18.2.3. By Reprocessing Method 15.18.2.4. By End User 15.19. South Africa 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Product Type 15.19.2.2. By Classification 15.19.2.3. By Reprocessing Method 15.19.2.4. By End User 15.20. Israel 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Product Type 15.20.2.2. By Classification 15.20.2.3. By Reprocessing Method 15.20.2.4. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product Type 16.3.3. By Classification 16.3.4. By Reprocessing Method 16.3.5. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Stryker Corporation 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Medline Industries, Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Johnson & Johnson (Ethicon) 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Medtronic plc 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Sterilmed, Inc. (a part of Johnson & Johnson) 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Centurion Medical Products Corporation 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Vanguard AG 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. ReNu Medical Inc. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. SureTek Medical 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Centurion Systems Pty Ltd. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Asia Pacific Reprocessed Medical Devices Market
